Jade Biosciences (JBIO) Other Non-Current Liabilities (2021 - 2025)
Jade Biosciences (JBIO) recorded Other Non-Current Liabilities of $70,000 in Q1 2025, unchanged from $70,000 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Jade Biosciences (JBIO) Other Non-Current Liabilities (2021 - 2025) Analysis & Trends
Starting with Q4 2021, Jade Biosciences' Other Non-Current Liabilities history includes 14 quarters.
- Annual Other Non-Current Liabilities has a three-year compound annual growth rate of 75.3% (FY2021 to FY2024).
- Across earlier years, Other Non-Current Liabilities came in at $70,000 in FY2023 (-1.4%), $71,000 in FY2022 (+446.2%) and $13,000 in FY2021.
- Quarterly Other Non-Current Liabilities has ranged from $13,000 in Q4 2021 to $71,000 in Q4 2022 over the past five years.
- On a year-over-year basis, Other Non-Current Liabilities rose in three of the last eight quarters, with growth averaging 108.7%.
- Peak year-over-year performance for Other Non-Current Liabilities in the last five years was growth of 446.2% in Q4 2022, against a decline of 1.4% in Q4 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $70,000 (Q4 2024), $70,000 (Q3 2024) and $70,000 (Q2 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Jade Biosciences | 892.96 Mn | 892.96 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 70,000.00 |
| Dec 31, 2024 | 70,000.00 |
| Sep 30, 2024 | 70,000.00 |
| Jun 30, 2024 | 70,000.00 |
| Mar 31, 2024 | 70,000.00 |
| Dec 31, 2023 | 70,000.00 |
| Sep 30, 2023 | 70,000.00 |
| Jun 30, 2023 | 69,000.00 |
| Mar 31, 2023 | 70,000.00 |
| Dec 31, 2022 | 71,000.00 |
| Sep 30, 2022 | 13,000.00 |
| Jun 30, 2022 | 13,000.00 |
| Mar 31, 2022 | 14,000.00 |
| Dec 31, 2021 | 13,000.00 |
API Access
Jade Biosciences Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=JBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "JBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=JBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();